Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hyeong Won Yu is active.

Publication


Featured researches published by Hyeong Won Yu.


Surgery | 2016

A novel lateral-approach laryngeal ultrasonography for vocal cord evaluation

Jung-Woo Woo; Hyunsuk Suh; Ra-Yeong Song; Joon-Hyop Lee; Hyeong Won Yu; Su Jin Kim; Young Jun Chai; June Young Choi; Kyu Eun Lee

BACKGROUND Laryngeal ultrasonography (LUS) is a new method of vocal cord (VC) evaluation in patients with risk of vocal cord palsy (VCP). The previously described anterior-approach LUS reportedly, however, has high failure rate of VC visualization in male patients. We devised a novel lateral-approach LUS to overcome this limitation. METHODS A total of 382 (82 male, 300 female) consecutive LUS and direct laryngoscopy (DL) examinations were performed on perioperative thyroidectomy and parathyroidectomy patients. The anterior-approach LUS was used for female patients whereas the lateral-approach LUS was used for male patients. Findings were cross-validated independently with DL examinations. RESULTS Both anterior and lateral LUS methods had 100% visualization rate (no failed visualization) with an overall sensitivity of 100% (23/23) and specificity of 99.2% (356/359) for VCP. Among the 300 female patients, 18 patients had VCP. Sensitivity and specificity of anterior-approach LUS were 100% (18/18) and 99.3% (280/282), respectively. Among the 80 male patients, 5 patients had VCP. Sensitivity and specificity of lateral-approach LU were 100% (5/5) and 98.7% (76/77), respectively. CONCLUSION The new LUS approach significantly enhances the visualization of vocal cords and, therefore, overall diagnostic efficacy of LUS in male patients.


Journal of Gastric Cancer | 2013

Risk factors of postoperative pancreatic fistula in curative gastric cancer surgery.

Hyeong Won Yu; Do Hyun Jung; Sang-Yong Son; Chang Min Lee; Ju Hee Lee; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim

Purpose Postoperative pancreatic fistula is a dreadful complication after gastric cancer surgery. The purpose of this study is to evaluate the actual incidence and risk factors of postoperative pancreatic fistula after curative gastrectomy for gastric cancer. Materials and Methods A total of 900 patients who underwent gastrectomy for gastric cancer (laparoscopic gastrectomy, 594 patients; open gastrectomy 306 patients) were enrolled between January 2009 and December 2010. Clinical outcomes, including postoperative pancreatic fistula grade based on the International Study Group on Pancreatic Fistula, were investigated. Results Overall, the postoperative pancreatic fistula rate was 3.3% (30/900) (1.5% in laparoscopic gastrectomy versus 6.9% in open gastrectomy, P<0.001). Patients who underwent D2 lymphadenectomy, total gastrectomy, splenectomy or distal pancreatectomy showed higher postoperative pancreatic fistula rates (4.7%, 13.8%, 13.6%, or 57.1%, respectively, P<0.001). Patients with postoperative pancreatic fistula had higher morbidity (46.7% versus 13.1%, P<0.001), delayed gas out (4.9 days versus 3.8 days, P<0.001), belated diet start (5.8 days versus 3.5 days, P<0.001) and longer postoperative hospital stay (13.7 days versus 6.8 days, P<0.001). On the multivariate analysis, total gastrectomy (odds ratio 9.751, 95% confidence interval: 3.348 to 28.397, P<0.001), distal pancreatectomy (odds ratio 7.637, 95% confidence interval: 1.668 to 34.961, P=0.009) and open gastrectomy (odds ratio 2.934, 95% confidence interval: 1.100 to 7.826, P=0.032) were the independent risk factors of postoperative pancreatic fistula. Conclusions Laparoscopic gastrectomy had an advantage over open gastrectomy in terms of the lower postoperative pancreatic fistula rate. Total gastrectomy and combined resection, such as distal pancreatectomy, should be performed carefully to minimize postoperative pancreatic fistula in gastric cancer surgery.


Journal of The Korean Surgical Society | 2015

Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study

Young Jun Chai; Jun Hyun Hong; Do Hoon Koo; Hyeong Won Yu; Joon Hyop Lee; Hyungju Kwon; Su Jin Kim; June Young Choi; Kyu Eun Lee

Purpose Primary thyroid lymphoma (PTL) is a rare disease and it has been investigated in a limited number of studies. The present multicenter study evaluated the clinical features and treatment outcomes of PTL. Methods The medical records of patients diagnosed with PTL between 2000 and 2013 in three centers were retrospectively reviewed. Results The study included 11 men and 27 women with a median age of 63.3 years (range, 42-83 years). The median follow-up was 56.0 months (range, 3-156 months). Of the 38 patients included, 16 had mucosa-associated lymphoid tissue (MALT) lymphoma, six had mixed MALT and diffuse large B-cell lymphoma (DLBCL), and 16 had DLBCL. Thirty-five patients (92.1%) had early stage (stage I/II) disease. Of the 16 MALT lymphoma patients, 14 were treated by surgery, and radiotherapy (RT) or chemotherapy was combined in five patients. Two patients received RT or chemotherapy alone. Of the six mixed MALT and DLBCL patients, three underwent surgery with chemotherapy and three underwent chemotherapy alone, RT alone, or surgery with RT. All of the 16 DLBCL patients received chemotherapy, and surgery and RT was combined in 4 and 1 patients, respectively. The 5-year survival was 100% for MALT lymphoma (7 of 7) and mixed MALT and DLBCL patients (5 of 5) and 87.5% for DLBCL patients (7 of 8). Conclusion Early stage PTL has an excellent prognosis when managed by single or combined treatment modalities. Clinicians should consider PTL in patients with underlying Hashimotos thyroiditis presenting with an enlarging thyroid mass.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2016

Postoperative nomogram for predicting disease-specific death and recurrence in papillary thyroid carcinoma.

Brian Hung-Hin Lang; Carlos K. H. Wong; Hyeong Won Yu; Kyu Eun Lee

A nomogram could provide individualized prognostic for papillary thyroid carcinoma (PTC). The purpose of our study was to develop and validate a new nomogram.


Annals of Surgical Oncology | 2017

Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor α/β Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients

Jin Wook Yi; Su Jin Kim; Jong Kyu Kim; Chan Yong Seong; Hyeong Won Yu; Young Jun Chai; June Young Choi; Kyu Eun Lee

BackgroundA gender disparity exists with respect to the incidence of papillary thyroid cancer (PTC), suggesting that sex hormones such as estrogen play a role in PTC development and progression. In this study, we compared estrogen receptor gene expression patterns in PTCs to determine the clinical significance of estrogen gene expression in PTC.MethodsWe analyzed ESR1 and ESR2 messenger RNA expression counts using data from The Cancer Genome Atlas (TCGA). To validate the results of TCGA analysis, we analyzed microarray data (GSE 54958) from the Gene Expression Omnibus.ResultsESR1 gene expression and ESR ratio (ESR1/ESR2) were significantly higher in PTC tissues than in paired normal thyroid tissues (mean 659.427 vs. 264.045 for ESR1, 92.017 vs. 19.064 for ESR ratio). Among female patients, ESR1 expression and ESR ratio were negatively correlated with increased age. ESR1 expression and ESR ratio were higher in patients with classic PTC, lymphovascular invasion, BRAFV600E mutation, and radioiodine therapy. Classification analysis demonstrated that higher ESR1 expression and a higher ESR ratio faced a worse overall survival (hazard ratio 6.348 for ESR1, 4.031 for ESR ratio). Validation microarray analysis demonstrated that ESR1 expression and ESR ratio were higher in tumor tissues, classic PTC, and BRAFV600E.ConclusionHigher ESR1 expression and a higher ESR ratio were associated with aggressive prognostic factors and worse overall survival in female PTC patients. Our results suggest that ESR1 and ESR ratio can be used as prognostic markers to predict female patient survival and have potential as a therapeutic target.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2017

Relationship between iodine levels and papillary thyroid carcinoma: A systematic review and meta‐analysis

Joon-Hyop Lee; Y. S. Hwang; Ra-Yeong Song; Jin Wook Yi; Hyeong Won Yu; Su Jin Kim; Young Jun Chai; June Young Choi; Kyu Eun Lee; Sue K. Park

Iodine excess has been suggested as an exogenous risk factor of papillary thyroid cancer (PTC). We performed a systematic review and meta‐analysis to assess the relationship between iodine exposure measured in various forms and PTC prevalence.


Endocrine connections | 2017

VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma

June Young Choi; Jin Wook Yi; Joon-Hyop Lee; Ra-Yeong Song; Hyeong Won Yu; Hyungju Kwon; Young Jun Chai; Su Jin Kim; Kyu Eun Lee

The purpose of this study was to assess the relationship between vitamin D receptor gene (VDR) expression and prognostic factors in papillary thyroid cancer (PTC). mRNA sequencing and somatic mutation data from The Cancer Genome Atlas (TCGA) were analyzed. VDR mRNA expression was compared to clinicopathologic variables by linear regression. Tree-based classification was applied to find cutoff and patients were split into low and high VDR group. Logistic regression, Kaplan–Meier analysis, differentially expressed gene (DEG) test and pathway analysis were performed to assess the differences between two VDR groups. VDR mRNA expression was elevated in PTC than that in normal thyroid tissue. VDR expressions were high in classic and tall-cell variant PTC and lateral neck node metastasis was present. High VDR group was also associated with classic and tall cell subtype, AJCC stage IV and lower recurrence-free survival. DEG test reveals that 545 genes were upregulated in high VDR group. Thyroid cancer-related pathways were enriched in high VDR group in pathway analyses. VDR mRNA overexpression was correlated with worse prognostic factors such as subtypes of papillary thyroid carcinoma that are known to be worse prognosis, lateral neck node metastasis, advanced stage and recurrence-free survival.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2016

Factors associated with the sensitivity of fine‐needle aspiration cytology for the diagnosis of follicular variant papillary thyroid carcinoma

Young Jun Chai; Hyunsuk Suh; Jin Wook Yi; Hyeong Won Yu; Joon-Hyop Lee; Su Jin Kim; Jae-Kyung Won; Kyu Eun Lee

The purpose of this study was to evaluate the factors associated with diagnostic accuracy of preoperative fine‐needle aspiration (FNA) for follicular variant papillary thyroid carcinoma (FVPTC).


Journal of The Korean Surgical Society | 2018

Transoral endoscopic surgery for papillary thyroid carcinoma: initial experiences of a single surgeon in South Korea

Jin Wook Yi; Sang Gab Yoon; Hyun Soo Kim; Hyeong Won Yu; Su Jin Kim; Young Jun Chai; June Young Choi; Kyu Eun Lee

Purpose The transoral endoscopic thyroid surgery vestibular approach (TOETVA) is one of the newest techniques which do not result in an anterior neck scar. We report herein our initial experience with TOETVA and its short-term outcomes in patients with papillary thyroid carcinoma (PTC). Methods This case series consisted of all consecutive patients who underwent TOETVA in our institution between August 2016 and June 2017. Indications for TOETVA were an fine needle aspiration-confirmed PTC or follicular neoplasm, an intrathyroidal tumor with a diameter of less than 2 cm, and no clinical evidence of central or lateral lymph node metastasis. A total of 20 patients underwent TOETVA and we retrospectively reviewed clinicopathologic data and short-term postoperative outcomes. Results Among the 20 TOETVA cases, 7 were total thyroidectomy, 12 were lobectomy and 1 was wide isthmusectomy. Mean age was 50.8 years and mean operation time was 152 ± 51.4 minutes. Tumor size ranged from 0.2–1.4 cm and the mean size of harvested central lymph nodes was 2.8 (range, 0–10). Neither mental nerve injury nor surgical site infection occurred. One patient had transient vocal cord palsy and 1 patient developed a neck seroma. Among 7 total thyroidectomy patients, 3 patients developed transient hypocalcemia. Conclusion Transoral thyroid surgery could be an alternative surgical option for some PTC patients.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2018

Novel method to save the parathyroid gland during thyroidectomy: Subcapsular saline injection

June Young Choi; Hyeong Won Yu; In Eui Bae; Jong-kyu Kim; Chan Yong Seong; Jin Wook Yi; Young Jun Chai; Su Jin Kim; Kyu Eun Lee

Saving the parathyroid gland during thyroidectomy remains challenging. Subcapsular saline injection (SCASI) was developed in February 2015. Its ability to spare the parathyroid gland was assessed.

Collaboration


Dive into the Hyeong Won Yu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

June Young Choi

Seoul National University Bundang Hospital

View shared research outputs
Top Co-Authors

Avatar

Young Jun Chai

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Su Jin Kim

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Jin Wook Yi

Seoul National University Hospital

View shared research outputs
Top Co-Authors

Avatar

Hyungju Kwon

Seoul National University Hospital

View shared research outputs
Top Co-Authors

Avatar

Joon-Hyop Lee

Seoul National University Bundang Hospital

View shared research outputs
Top Co-Authors

Avatar

Ra-Yeong Song

Seoul National University Hospital

View shared research outputs
Top Co-Authors

Avatar

Chan Yong Seong

Seoul National University Hospital

View shared research outputs
Top Co-Authors

Avatar

In Eui Bae

Seoul National University Bundang Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge